Facebook Follow AMS on Linkedin Follow us on Twitter @amsmenopausen AMS on Instagram

Menopause Videos from The Menopause Society

The Menopause Society (formerly the North American Menopause Society (NAMS)) presents its comprehensive video series for clinicians about important midlife health topics. All of the interviews in the series are hosted by NAMS Board of Trustees Member and Past-President Dr Marla Shapiro, a Canadian physician, who led this exciting initiative. Dr Shapiro is also the medical consultant for CTV News and on-air medical contributor to Canada AM.

Note: The Australasian Menopause Society does not necessarily endorse the medical and scientific information provided in these videos. As the medical and scientific information provided here might not be relevant to a particular person's circumstances and you should always discuss your health with your own healthcare provider.

Duration of Hormone Therapy Use

James H Liu, MD, NCMP

2018-2019 NAMS President
Arthur H Bill Professor and Chair
Department of Obstetrics and Gynecology
University Hospitals/MacDonald Women’s Hospital
Department of Reproductive Biology
Case Western Reserve School of Medicine
Cleveland, OH USA

Dr James Liu discusses the risks and benefits of long-term therapy use.

Continue Reading

Print Email

Effects of Stress on Health

Dr Rebecca Thurston

Director of the Women’s Biobehavioral Health Laboratory and Professor of Psychiatry, Psychology, Epidemiology, and Clinical and Translational Science at the University of Pittsburgh.

Dr Rebecca Thurston discusses current research regarding the effects of stress on health.

Continue Reading

Print Email

Pharmacologic Nonhormone Options for Vasomotor Symptoms

James A Simon, MD, CCD, NCMP, IF, FACOG

Clinical Professor
Department of Obstetrics and Gynecology
The George Washington University School of Medicine
Washington, DC

Dr James Simon explains what pharmacologic nonhormone options work for hot flushes.

Continue Reading

Print Email

Facts About Nonpharmacologic Options for Vasomotor Symptoms

Dr Risa Kagan MD, FACOG, CCD, NCMP

Clinical Professor Department of Obstetrics, Gynecology, and Reproductive Sciences University of California, San Francisco East Bay Physicians Medical Group Berkeley, California.

Dr Kagan explains the evidence available for popular nonpharmacologic options for the treatment of vasomotor symptoms.

Continue Reading

Print Email

What We Know About Estrogen and Cardiovascular Health

Dr Cynthia Stuenkel

Clinical Professor of Medicine, University of California San Diego.

Dr Stuenkel explains the safety and efficacy of estrogen throughout a woman’s life stages.

Continue Reading

Print Email

New Treatment Options for Lowering LDL Cholesterol

Dr Howard Hodis

Professor of Medicine and Preventive Medicine and Director of the Atherosclerosis Research Unit, Keck School of Medicine at the University of Southern California in Los Angeles.

Dr Hodis explains indications and risk factors for the new class of lipid-lowering drugs. In addition, he discusses the gender differences in cardiovascular disease.

Continue Reading

Print Email

Diagnosis and treatment options for bone health

Dr Felicia Cosman MD

Medical Director of the Clinical Research Center at Helen Hayes Hospital and Professor of Medicine at Columbia University College of Physicians and Surgeons in New York.

Dr Cosman explains vertebral and osteoporotic fractures, risk levels, and antiresorptive and anabolic therapies and shares thoughts on drug holidays.

Continue Reading

Print Email

Clinical Consideration for the Treatment of GSM

Dr Nick Panay, MSc, MBBS, FRCOG, MFSHR

Honorary Senior Lecturer, Imperial College Director, West London Menopause and PMS Center Queen Charlotte’s and Chelsea Westminster Hospitals General Secretary-Elect of the International Menopause Society

Dr Panay reviews why discussion of treatment options for genitourinary syndrome of menopause (GSM) is often overlooked in patient visits. He explains the differences in performance and frequency of use of both moisturizers and lubricants and how the FDA-approved nonestrogen prasterone works.

Continue Reading

Print Email

The Timing Hypothesis

Dr Peter Schnatz

Past President of NAMS and Associate Chairman and Residency Program Director in the Department of Obstetrics and Gynecology at the Reading Hospital in Reading, Pennsylvania.

Dr Schnatz discusses the benefits of starting women on hormone therapy at the beginning of the menopause transition, along with the cardiovascular health advantages.   

Continue Reading

Print Email

Contraception in Perimenopause

Dr Andrew Kaunitz

Dr Kaunitz is an obstetrician-gynecologist in Jacksonville, Florida and is affiliated with multiple hospitals in the area, including UF Health Jacksonville and UF Health Shands Hospital.

Dr Kaunitz discusses the appropriate type of contraceptive for women, including those at risk.

Continue Reading

Print Email

Search

Facebook Follow AMS on Linkedin Follow us on Twitter @amsmenopauseAMS on Instagram